We are live on ! Find out more
Berkshire Hathaway

Berkshire Hathaway Portfolio holdings

AUM $263B
1-Year Est. Return 16.68%
 

Berkshire Hathaway is an American multinational conglomerate holding company headquartered in Omaha, Nebraska. Chaired by legendary investor Warren Buffett, it is known for its diverse range of subsidiaries and investments—spanning industries such as insurance, rail transportation, energy, manufacturing, and retail. Over the decades, Berkshire’s patient and value-oriented approach to investing has earned it a reputation for long-term stability and significant growth, turning it into one of the largest and most influential corporations in the world.

This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+16.68%
3 Year Est. Return
+59.22%
5 Year Est. Return
+100.95%
10 Year Est. Return
+340.48%
AUM
$331B
AUM Growth
+$37.5B
Cap. Flow
-$674M
Cap. Flow %
-0.2%
Top 10 Hldgs %
89.54%
Holding
46
New
3
Increased
4
Reduced
8
Closed
2

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.34B
2
BMY icon
Bristol-Myers Squibb
BMY
+$988M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$417M
4
MRSH
Marsh
MRSH
+$388M
5
V icon
Visa
V
+$272M

Sector Composition

Rank Sector Weight
1 Technology 49.56%
2 Financials 29.29%
3 Consumer Staples 11.56%
4 Communication Services 3.49%
5 Consumer Discretionary 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOR
26
DELISTED
STORE Capital Corporation
STOR
$840M 0.25%
24,415,168
TMUS icon
27
T-Mobile US
TMUS
$186B
$608M 0.18%
5,242,000
GL icon
28
Globe Life
GL
$14.2B
$595M 0.18%
6,353,727
ABBV icon
29
AbbVie
ABBV
$455B
$411M 0.12%
3,033,561
-11,364,927
-79% -$1.34B
RPRX icon
30
Royalty Pharma
RPRX
$26.2B
$345M 0.1%
8,648,268
-4,497,634
-34% -$175M
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$324M 0.1%
5,202,674
-16,844,262
-76% -$988M
STNE icon
32
StoneCo
STNE
$2.78B
$180M 0.05%
10,695,448
FWONK icon
33
Liberty Media Series C
FWONK
$25.1B
$134M 0.04%
+2,191,396
New +$123M
FND icon
34
Floor & Decor
FND
$5.98B
$110M 0.03%
843,709
+26,846
+3% +$3.46M
MRSH
35
Marsh
MRSH
$91.4B
$70.4M 0.02%
404,911
-2,336,844
-85% -$388M
JNJ icon
36
Johnson & Johnson
JNJ
$617B
$56M 0.02%
327,100
PG icon
37
Procter & Gamble
PG
$335B
$51.6M 0.02%
315,400
MDLZ icon
38
Mondelez International
MDLZ
$80.5B
$38.3M 0.01%
578,000
WFC icon
39
Wells Fargo
WFC
$258B
$32.4M 0.01%
675,054
LILA icon
40
Liberty Latin America Class A
LILA
$1.63B
$30.7M 0.01%
3,872,526
VOO icon
41
Vanguard S&P 500 ETF
VOO
$972B
$18.8M 0.01%
43,000
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$18.7M 0.01%
39,400
LILAK icon
43
Liberty Latin America Class C
LILAK
$1.61B
$14.6M ﹤0.01%
1,412,422
UPS icon
44
United Parcel Service
UPS
$89.5B
$12.7M ﹤0.01%
59,400
SIRI icon
45
SiriusXM
SIRI
$10.4B
-4,365,880
Closed -$266M
TEVA icon
46
Teva Pharmaceuticals
TEVA
$41.2B
-42,789,295
Closed -$417M

Similar funds

Berkshire Hathaway's Q4 2021 Portfolio in Review

As of Q4 2021, Berkshire Hathaway held 46 positions worth $331B, up 13% from $293B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Berkshire Hathaway's Q4 2021 filing shows 3 new, 4 increased, 8 reduced and 2 closed positions. Its largest new stake was Nu Holdings: 107,118,784 shares worth $1B. The largest sale was AbbVie, an estimated $1.34B.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 44% a quarter earlier, followed by Financials and Consumer Staples.

  • Berkshire Hathaway's largest Q4 2021 buy was Nu Holdings: 107,118,784 shares worth $1B.
  • Berkshire Hathaway added most to Chevron in Q4 2021, an estimated $1.08B increase.
  • Berkshire Hathaway's biggest Q4 2021 reduction was AbbVie, cutting an estimated $1.34B.
  • Berkshire Hathaway fully exited Teva Pharmaceuticals in Q4 2021, selling an estimated $417M.
  • Berkshire Hathaway's ten largest holdings make up 90% of its $331B portfolio in Q4 2021.
  • Berkshire Hathaway opened 3 new positions and closed 2 in Q4 2021.
  • Berkshire Hathaway's portfolio value rose 13% quarter-over-quarter to $331B.

Based on Berkshire Hathaway's 13F filing for Q4 2021, filed 14 Feb 2022.